Heterocyclic Cage Compounds
208 216
was added via cannula to a solution of LDA (1.2 equiv) at À788C in THF
(20 mL). After 30 min of stirring, N-(tert-butoxycarbonyl)-2-methyl-p-
benzoquinonmonoimine dimethylacetal 2[16] (1.53 g, 5.7 mmol, 1.1 equiv) in
THF (20 mL) was added at À788C. The mixture was stirred for 5 h.
Hydrolysis was performed with saturated NH4Cl, and the residue was
extracted with AcOEt. The organic phase was dried (Na2SO4) and
concentrated in vacuo. An aqueous solution of oxalic acid (10%, 2 mL)
was added at RT to the resulting acetal derivatives 4, which were dissolved
in THF (20 mL). After 2 h of stirring, the solution was neutralized with
saturated NaHCO3. The organic phase was extracted with AcOEt, dried
(Na2SO4), and concentrated in vacuo to give a mixture of [4R,(S)R]-6 and
[4S,(S)R]-6 (77:23, 82% overall yield), which could be separated by column
chromatography (hexane/AcOEt 4:1) to afford [4R,(S)R]-6 (1.1 g, 58%
yield) and [4S,(S)R]-6 (360 mg, 19% yield) as white solids.
(brs, 3H; CH3), 1.83 (brs, 2H; NH2); 13C NMR (50 MHz): 184.9 (CO),
160.5 (C-3), 151.9 (C-5), 142.1 (C; Tol), 140.0 (C; Tol), 130.1 (2C; Tol),
128.2 (C-2), 127.3 (C-6), 123.9 (2C; Tol), 67.8 (CH2SOTol), 52.9 (C-4), 21.3
(Tol), 18.3 (CH3); HRMS (FAB ) calcd for C15H17NO2S: m/z: 276.1061
[M] , found 276.1058.
[1R,2R,5S,6R,8S,9R,(S)R] and [1S,2S,5R,6S,8R,9S,(S)R]-8-[(p-tolyl-
sulfinyl)methyl]-3-oxa-7-azatetracyclo [6.4.0.02,6.05,9]dodecane-4,11-dione
(12a/12b): 2-(Trimethylsilyloxy)furan 11 (20.3 mg, 0.13 mmol, 1.2 equiv)
and Bu4NF (1m in THF, 130 mL, 1.1 equiv) were sequentially added at RT to
a solution of 7 (30 mg, 0.11 mmol, 1 equiv) in dry CH2Cl2 (0.5 mL). After
1 h of stirring, a saturated aqueous solution of NaCl was added. The
solution was extracted with AcOEt, and the combined organic phases were
dried (Na2SO4). Removal of the solvent in vacuo afforded a residue, which
was purified by column chromatography (CH3CN/CH2Cl2 4:1). Com-
pounds 12a and 12b were obtained as white solids as a 1:1 mixture of two
diastereomers. Yield: 25.5 mg, 67%; 1H NMR (300 MHz): 7.59 7.56 (AA',
2H; Tol, two diastereomers), 7.38 7.36 (BB', 2H; Tol, two diastereomers),
4.80 4.79 (m, 1H; H-2, two diastereomers), 4.58 4.54 (m, 1H; H-6, two
diastereomers), 3.36, 3.07 (ABsystem, J 14.1 Hz, 2H; CH2SOTol, one
diastereomer), 3.32, 3.03 (ABsystem J 13.7 Hz, 2H; CH2SOTol, one
diastereomer), 3.13 (brs, 1H; H-1, two diastereomers), 2.90 2.30 (m, 6H;
two diastereomers), 2.46 (s, 3H; Tol, two diastereomers); 13C NMR
(75 MHz): 203.8 (CO; two diastereomers), 175.8 (CO), 175.7 (CO), 142.5
(Tol; two diastereomers), 140.1 (Tol; two diastereomers), 130.4 (2C, Tol;
two diastereomers), 123.9 (2C, Tol; two diastereomers), 81.1 (C-2), 80.0 (C-
2), 64.3 (C-8), 64.2 (C-8), 63.9 (CH2SOTol; two diastereomers), 58.9 (C-6),
58.7 (C-6), 45.9 (C-5), 45.8 (C-5), 45.2 (C-1), 44.5 (C-1), 44.1 (C-9), 43.7 (C-
9), 36.8 (C-12), 36.7 (C-10), 35.5 (C-12), 35.4 (C-10), 21.4 (Tol; two
diastereomers); HRMS(EI) calcd for C18H19NO4S: m/z: 345.1036, found
345.1034.
[4R,(S)R]-6: M.p. 136 1378C; [a]2D0 60.1 (c 1 in CHCl3); 1H NMR
(200 MHz): 7.48 7.44 (AA', 2H; Tol), 7.39 (d, J 11.2 Hz, 1H; H-5), 7.29
7.26 (BB', 2H; Tol), 6.91 (brs, 1H; NH), 6.39 (dd, J 11.2 and 2.1 Hz, 1H;
H-6), 6.07 (brs, 1H; H-2), 3.15 and 2.42 (ABsystem, J 13.3 Hz, 2H;
CH2SOTol), 2.41 (s, 3H; Tol), 1.91 (d, J 1.6 Hz, 3H; CH3), 1.37 (s, 9H;
tBu); 13C NMR (75 MHz): 184.7 (CO), 160.3 (CO), 154.1 (C-3), 150.6 (C-5),
142.9 (C; Tol), 140.1 (C; Tol), 129.9 (2C; Tol), 130 (CH), 127.8 (CH), 124.0
(2C; Tol), 80.78 (C; tBu), 67.2 (CH2SOTol), 57.7 (C-4), 28.4 (3C; tBu), 21.7
(Tol), 18.8 (CH3); elemental analysis calcd for C20H25NO4S: C 63.97, H 6.71,
N 3.73, S 8.54; found C 63.98, H 6.68, N 3.55, S 8.65.
[4S,(S)R]-6: M.p. 121 1228C; [a]2D0 30 (c 1 in CHCl3); 1H NMR
(300 MHz): 7.51 7.47 (AA', 2H; Tol), 7.34 7.30 (BB', 2H; Tol), 6.92 (d,
1H, J 10.2 Hz; H-5), 6.63 (brs, 1H; NH), 6.24 6.15 (m, 2H; H-6 and
H-2), 3.00, 2.80 (ABsystem, J 13.4 Hz, 2H; CH2SOTol), 2.39 (s, 3H; Tol),
2.21 (s, 3H; CH3), 1.38 (s, 9H; tBu); 13C NMR (75 MHz): 184.7 (CO), 159.1
(CO), 154.0 (C-3), 151.1 (C-5), 142.0 (C; Tol), 139.2 (C; Tol), 129.5 (2C;
Tol), 128.1 (CH), 127 (CH), 123.4 (2C; Tol), 80.6 (C; tBu), 65.7
(CH2SOTol), 57.3 (C-4), 27.7 (3C; tBu), 21.2 (Tol), 19.2 (CH3).
[1R,2R,5S,6R,8R,9R,(S)R]-9-Methyl-8-[(p-tolylsulfinyl)methyl]-3-oxa-
7-azatetracyclo[6.4.0.02,6.05,9]dodecane-4,11-dione (13a): 2-(Trimethylsilyl-
oxy)furan 11 (33.7 mg, 0.21 mmol, 1.8 equiv) and Bu4NF (1m in THF,
132 mL, 0.13 mmol, 1.1 equiv) were sequentially added at room temper-
ature to a solution of [4R,(S)R]-8 (32 mg, 0.12 mmol, 1 equiv) in dry CH2Cl2
(0.5 mL). After 24 h of stirring, a saturated aqueous solution of NaCl was
added. Extractions were carried out with AcOEt, and the combined
organic phases were dried (Na2SO4). Removal of the solvent in vacuo
afforded a residue that was purified by column chromatography (CH3CN/
CH2Cl2 3:1) to give 13a as a white solid. Yield: 24 mg, 56%; m.p. 249
[(S)R]-4-amino-4-[p-(tolylsulfinyl)methyl]cyclohexa-2,5-dienone (7): TFA
(10 equiv) was added to a solution of 5 (3 g, 8.3 mmol, 1 equiv) in CH2Cl2
(40 mL). The mixture was stirred at RT for 2 h, and an aqueous solution of
NaOH (2m) was added slowly at 08C until the pH was basic. The product
mixture was extracted with AcOEt, and the combined organic phases were
washed with brine and dried (Na2SO4). After removal of the solvent in
vacuo, the residue was recrystallized from AcOEt to afford a white solid.
Yield: 2.1 g, 97%; m.p. 162 1638C; [a]2D0 146 (c 1 in CHCl3);
1H NMR (300 MHz): 7.54 7.50 (AA', 2H; Tol), 7.35 7.31 (BB', 2H;
Tol), 7.15 (dd, J 9.6 and 3.2 Hz, 1H; H-3), 6.99 (dd, J 9.6 and 3.2 Hz,
1H; H-5), 6.27 (dd, J 9.6 and 1.6 Hz, 1H; H-2), 6.19 (dd, J 9.6 and
1.6 Hz, 1H; H-6), 3.10, 2.75 (ABsystem, J 13.4 Hz, 2H; CH2SOTol), 2.41
(s, 3H; Tol), 2.01 (brs, 2H; NH2); 13C NMR (75 MHz): 184 (CO), 151.0 (C-
3), 150.8 (C-5), 142.2 (C; Tol), 140.3 (C; Tol), 130.1 (2C; Tol), 128.0 (C-2),
127.8 (C-6), 123.8 (2C; Tol), 67.2 (CH2SOTol), 53.0 (C-4), 21.3 (Tol).
1
2508C; [a]2D0 140 (c 1.05 in MeOH); H NMR (200 MHz): 7.62 7.59
(AA', 2H; Tol), 7.41 7.38 (BB', 2H; Tol), 4.86 (dd, J 8.0 and 4.9 Hz, 1H;
H-2), 4.49 (brt, J 4.9 Hz, 1H; H-6), 3.27, 2.85 (ABsystem, J 13.1 Hz,
2H; CH2SOTol), 3.03 2.93 (m, 1H; H-1), 2.70 2.49 [m, 3H; H-12a, H-12e,
H-10e), 2.43 (s, 3H; Tol), 2.32 (d, J 4.9 Hz, 1H; H-5), 2.15 (part Bof AB '
system, J 16.3 Hz, 1H; H-10a), 1.09 (s, 3H; CH3); 13C NMR (50 MHz):
204.1 (CO), 175.6 (CO), 142.5 (Tol), 139.9 (Tol), 130.3 (2C; Tol), 124.0 (2C;
Tol), 82.0 (C-2), 66.3 (C-8), 63.1 (C-6), 56.5 (CH2SOTol), 50.5 (C-5), 48.8
(C-9), 44.9 (C-1), 44.3 (C-10), 36.3 (C-12), 25.5 (CH3), 21.4 (Tol).
[4R,(S)R]-4-Amino-3-methyl-4-[p-(tolylsulfinyl)methyl]cyclohexa-2,5-di-
enone [4R,(S)R]-(8): TFA (10 equiv) was added to a solution of [4R,(S)R]-
6 (1.1 g, 2.9 mol, 1 equiv) in CH2Cl2 (50 mL). The mixture was stirred at RT
for 1 h, then aqueous NaOH (2m) was added slowly at 08C until the pH was
basic. The mixture was extracted with AcOEt. The combined extracts were
washed with brine and dried (Na2SO4). After removal of the solvent in
vacuo, the residue was recrystallized from AcOEt to afford a white solid.
Yield: 694 mg, 87%; m.p. 118 1198C; [a]2D0 130 (c 1 in CHCl3);
1H NMR (300 MHz): 7.47 7.44 (AA', 2H; Tol), 7.34 (d, J 10.1 Hz, 1H;
H-5), 7.30 7.28 (BB', 2H; Tol), 6.25 (dd, J 10.1 and 2 Hz, 1H; H-6), 6.04
(brs, 1H; H-2), 3.20, 2.65 (ABsystem, J 13.3 Hz, 2H; CH2SOTol), 2.36 (s,
3H; Tol), 1.99 (d, J 1.2 Hz, 3H; CH3), 1.95 (brs, 2H; NH2); 13C NMR
(50 MHz): 184.9 (CO), 159.9 (C-3), 151.9 (C-5), 142.0 (C; Tol), 140.6 (C;
Tol), 130.0 (2C; Tol), 127.4 (C-2), 127.2 (C-6), 123.7 (2C; Tol), 66.9
(CH2SOTol), 55.1 (C-4), 21.2 (Tol), 18.5.
[1S,2S,5R,6S,8R,9S,(S)R]-9-Methyl-8-[(p-tolylsulfinyl)methyl]-3-oxa-7-
azatetracyclo[6.4.0.02,6.05,9] dodecane-4,11-dione (13b): 2-(Trimethylsilyl-
oxy)furan 11 (37.5 mg, 0.24 mmol, 1.8 equiv) and Bu4NF (1m in THF,
156 mL, 1.2 equiv) were sequentially added at RT to a solution of [4S,(S)R]-
8 (37 mg, 0.13 mmol, 1 equiv) in dry CH2Cl2 (0.5 mL). After 24 h of stirring,
a saturated aqueous solution of NaCl was added. Extraction was carried out
with AcOEt, and the combined organic phases were dried (Na2SO4).
Removal of the solvent in vacuo, afforded a crude product which was
purified by column chromatography (CH3CN/CH2Cl2 3:1) to give 13b as a
white solid. Yield: 33 mg, 70%; m.p. 203 2048C; [a]2D0 170 (c 1 in
CHCl3); 1H NMR (200 MHz): 7.58 7.55 (AA', 2H; Tol), 7.38 7.35 (BB',
2H; Tol), 4.84 (dd, J 8.0 and 4.8 Hz, 1H, H-2), 4.52 (brt, J 4.8 Hz, 1H;
H-6), 3.10, 3.01 (ABsystem, J 13.1 Hz, 2H; CH2SOTol), 3.01 2.98 (m,
1H; H-1), 2.68 2.62 [m, 3H; H-12a, H-12e, H-10e), 2.42 (s, 3H; Tol), 2.36 (d,
J 4.8 Hz, 1H; H-5), 2.16 (part Bof AB ' system, J 16.0 Hz, 1H; H-10a),
1.09 (s, 3H; CH3); 13C NMR (75 MHz): 204.6 (CO), 175.5 (CO), 142.3 (Tol),
140.7 (Tol), 130.3 (2C; Tol), 123.8 (2C; Tol), 81.4 (C-2), 66.5 (C-8), 63.5 (C-
6), 58.0 (CH2SOTol), 51.7 (C-5), 48.9 (C-9), 45.7 (C-10), 45.0 (C-1), 36.3 (C-
12), 25.6 (CH3), 21.5 (Tol): HRMS(EI) calcd for C19H21NO4S: m/z:
359.1191, found 359.1189.
[4S,(S)R]-4-Amino-3-methyl-4-[p-(tolylsulfinyl)methyl]cyclohexa-2,5-di-
enone [4S,(S)R]-(8): Starting from [4S,(S)R]-6 (360 mg, 0.96 mmol,
1 equiv) and following the procedure for the synthesis of [4R,(S)R]-8, the
diastereomer [4S,(S)R]-8 was obtained as a white solid. Yield: 262 mg,
99%; m.p. 168 1698C; [a]2D0 242 (c 1 in CHCl3); 1H NMR
(300 MHz): 7.49 7.46 (AA', 2H; Tol), 7.31 7.28 (BB', 2H; Tol), 7.03 (d,
J 10.6 Hz, 1H; H-5), 6.16 (dd, J 10 and 1.8 Hz, 1H; H-6), 6.13 (brs, 1H;
H-2), 3.05, 2.93 (ABsystem, J 13.3 Hz, 2H; CH2SOTol), 2.39 (s, 3H), 2.13
[1S, 2R, 5S, 6R, 8S, 9R, (S)R] and [1R, 2S, 5R, 6S, 8R, 9S, (S)R]-8-
[(p-Tolylsulfinyl)methyl]-3,7-dioxa tetracyclo[6.4.0.02,6.05,9]dodecane-4,11-
Chem. Eur. J. 2002, 8, No. 1
¹ WILEY-VCH Verlag GmbH, 69451 Weinheim, Germany, 2002
0947-6539/02/0801-0213 $ 17.50+.50/0
213